BioSistemika

Executive Summary

BioSistemika is a European software company specializing in custom laboratory informatics and data management solutions for the life sciences, pharmaceutical, and in-vitro diagnostics (IVD) sectors. Founded in 2010 and headquartered in Ljubljana, Slovenia, the company offers regulatory-compliant software, digitalization consulting, and innovative products to streamline laboratory workflows. With a focus on enhancing efficiency and compliance in regulated environments, BioSistemika serves a niche but critical market, helping clients manage complex data and automate processes. The company also invests internally in a DNA data storage research project, positioning itself at the intersection of digital health and cutting-edge biotechnology. Despite limited public financial data and a private status, BioSistemika demonstrates potential for growth through its specialized offerings and R&D initiatives. The growing demand for laboratory automation and digital transformation in pharma and diagnostics provides a favorable tailwind. The DNA storage project, though early-stage, could open new horizons if successful. Key risks include competition from larger players and the need for sustained innovation. Overall, the company is well-positioned in a growing sector, but investor visibility is low. Conviction score is moderate given the lack of transparency and stage uncertainty.

Upcoming Catalysts (preview)

• Q3 2026Launch of next-generation cloud-based LIMS platform80% success
• H2 2026Strategic partnership with a top-10 pharma company for lab digitalization60% success
• Q4 2026Proof-of-concept milestone for DNA data storage technology40% success